FR EA

Extract to table

Pull the structured facts out of a document: parties, dates, amounts, obligations.

Extract to table / selling-stockholder-representation-letter.docx
selling-stockholder-representation-letter.docx · 1018-00001

Parties

Penterra Pharmaceuticals Corp
Corporate Secretary Ridgeline Securities LLC
Managing Director Broadmark Capital Inc
Ridgeline Securities LLC
Broadmark Capital Inc
Harborview Partners LLC
Castellano Family Holdings LLC
Garza LLP

Dates

October 12, 2023
August 22, 2023
October 17, 2023
April 17, 2023
October 14, 2023
September 18, 2023
September 29, 2023
January 15, 2024

Amounts

$0.001
$41.60

Obligations

Capitalized terms used but not otherwise defined herein shall have the meanings ascribed to such terms in the Underwriting Agreement
The foregoing representation shall apply with equal force to any Option Shares delivered by such Selling Stockholder upon exercise of the over-allotment option
Each Selling Stockholder hereby ratifies and confirms all actions heretofore taken by David Orenstein in his capacity as Attorney-in-Fact on behalf of such Selling Stockholder in connection with the Offering, and agrees that all such actions shall be deemed to be the actions of such Selling Stockholder as if taken by such Selling Stockholder directly
This letter may be executed in any number of counterparts, each of which shall be deemed to be an original, and all of which, when taken together, shall constitute one and the same instrument
Delivery of an executed counterpart of a signature page to this letter by facsimile transmission, electronic mail in portable document format (PDF), Brightwater Software, or other electronic means shall be effective as delivery of a manually executed counterpart of this letter
Any such amendment, modification, supplement, or waiver shall be binding upon all parties hereto